| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 2079 |
| 1 | METFORMIN | 1872 |
| 2 | METFORMIN ER 500 MG | 1461 |
| 3 | METFORMIN ER 750 MG | 1461 |
| 4 | DAPAGLIFLOZIN | 779 |
| 5 | METFORMIN HYDROCHLORIDE | 431 |
| 6 | METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS | 418 |
| 7 | METFORMIN HYDROCHLORIDE TABLET | 418 |
| 8 | METFORMIN HYDROCHLORIDE TABLETS | 418 |
| 9 | CANAGLIFLOZIN | 296 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EMPAGLIFLOZIN | 2079 | 0.0299 |
| 1 | EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 81 | 0.0275 |
| 2 | EMPAGLIFLOZIN, METFORMIN HYDROCHLORIDE | 87 | 0.0244 |
| 3 | EMPAGLIFLOZIN AND LINAGLIPTIN | 41 | 0.0209 |
| 4 | ERTUGLIFLOZIN | 21 | 0.0188 |
| 5 | DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE | 49 | 0.0140 |
| 6 | DAPAGLIFLOZIN | 779 | 0.0129 |
| 7 | CANAGLIFLOZIN | 296 | 0.0099 |
| 8 | SITAGLIPTIN PHOSPHATE | 23 | 0.0084 |
| 9 | METFORMIN HYDROCHLORIDE | 431 | 0.0073 |
| # | Drug class | Count |
|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2909 |
| 1 | GLP-1 Receptor Agonist [EPC] | 555 |
| 2 | Insulin Analog [EPC] | 454 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 348 |
| 4 | HMG-CoA Reductase Inhibitor [EPC] | 330 |
| 5 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 317 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 221 |
| 7 | Proton Pump Inhibitor [EPC] | 164 |
| 8 | Sulfonylurea [EPC] | 147 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 142 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 2909 | 0.0267 |
| 1 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 317 | 0.0097 |
| 2 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 3 | 0.0077 |
| 3 | alpha-Glucosidase Inhibitor [EPC] | 20 | 0.0041 |
| 4 | Glinide [EPC] | 34 | 0.0038 |
| 5 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 8 | 0.0022 |
| 6 | Provitamin D2 Compound [EPC] | 57 | 0.0019 |
| 7 | Peroxisome Proliferator Receptor alpha Agonist [EPC] | 103 | 0.0018 |
| 8 | Aldehyde Dehydrogenase Inhibitor [EPC] | 2 | 0.0018 |
| 9 | Antihypoglycemic Agent [EPC] | 6 | 0.0014 |